P. Coto-Segura-rekin lankidetzan egindako argitalpenak (9)

2024

  1. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

    International Journal of Dermatology, Vol. 63, Núm. 4, pp. 503-511

2023

  1. High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting

    International Journal of Dermatology

2022

  1. Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting

    Dermatologic Therapy, Vol. 35, Núm. 8

  2. Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients

    Dermatologic Therapy, Vol. 35, Núm. 12

2021

  1. Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

    Dermatology and Therapy, Vol. 11, Núm. 6, pp. 2207-2215

2020

  1. Dermatologists’ Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 10, pp. 835-846

  2. Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4)

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 655-664

2016

  1. Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations

    Actas dermo-sifiliograficas, Vol. 107, Núm. 3, pp. 194-206

  2. Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations

    Actas Dermo-Sifiliograficas, Vol. 107, Núm. 3, pp. 194-206